Please don't jinx it W69 !
Printable View
Please don't jinx it W69 !
Sturdy result
Home Care:Dominated by Resmed.FHP strategy to have better product,right technology for customer,competive landscape reduced
R & D spend & new technologies constantly increasing
Anaesthesia /hospital products good potential,excited even,increased sales personal for anesthesia.
Dependant on regulators work flow.
Gross margins improving,lower freight costs(lower air freight) & stock levels =/- 50 basis points,a lot of moving parts,100+ improvement in Gross Margins over 5 years?
Goal 30 % operating margin,60 % gross margins.
Taken write down downs on land,product recall ,tax impacts in their stride,all out of cash flow.
Recall is for a 7-10 yr old product so assuming all acounted for in the $20m
Phone conference:Panel fully in touch with their business,performance & how products are performing.Transparent.
CAPEX;lumpiness,dependant on build in NZ ,mainly 2026,27.Dependant on requirements,building ahead.
Increasing OPEX across all the business
Foundations all there for continual improvement
World class
FPH caugh the Fletcher bug I note
+35% NPAT guidance for FY 25 is doing wonders to FPH ...:t_up:
Yep great result Alokdhir
I wonder if Couta still holds?
$17 Billion market cap?
it’s history of revenue & net income growth does not at all warrant a $17 Billion valuation. You can have all the IP moats in the world, but that doesn’t mean it has enough growth to warrant the current earnings multiple.
Attachment 15128